Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sports Reactions Center Says Steroid Use Unnecessary in Wake of Baseball Scandal—Athletes Can Gain High Performance Naturally
  • USA - English


News provided by

JoTo PR

Sep 30, 2013, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Athletes who take proper care of their body are doing themselves a favor—artificial enhancements are not only illegal, but also unnecessary and unadvised.

Post this

Bellevue, WA (PRWEB) September 30, 2013 -- In a time when illegal steroid use has shamed many professional athletes—yet also inadvertently rewarded them with lucrative sports contracts—studies have found that young athletes feel the pressure to use the drugs, as well, despite their dangerous side effects. After Major League Baseball’s (MLB) recent suspension of star player Alex Rodriguez, Sports Reaction Center (SRC), a sports physical therapy center that attracts amateur and professional athletes both locally and nationally, says young athletes should not be tempted to use steroids. SRC provides athletes with the means of achieving their best performance naturally.

The MLB has taken a zero-tolerance stance against steroid use by suspending a total of 13 players. Despite this, a new study highlights that young athletes are still being heavily influenced by professionals’ decisions to use performing enhancing drugs (PEDs):

●Nearly half of males aged 18-25 thought that taking PEDs was critical to making it in professional sports or enhancing one’s athletic performance;

●More than three quarters of both young males and parents in our survey said that pro athletes using PEDs has put pressure on young athletes to use drugs, as well;

●Fifty-eight percent of these young males thought that at least one-third of the major leaguers on the rosters in last week’s All-Star Game had used PEDs. (1)

As a facility devoted to fostering the talent of aspiring athletes, SRC counsels teenagers to avoid PEDs and focus instead on rest and nutrition as key approaches to enhancing performance in addition to their training. SRC also offers a technology-based solution in its CoreControl system, which uses a cooling device to improve muscle recovery, which, in turn, increases output potential, making the result “better than steroids.”

SRC founder, Neil Chasan, says that many young athletes are enticed by the allure of PEDs because of the material success of professional athletes. However, per Chasan, what many young adults fail to comprehend is that the side effects of illegal steroid use are often severe and dangerous, such as:

●Increased risk of tendonitis and tendon rupture;
●Liver abnormalities and tumors;
●Heart and circulatory problems;
●Aggressive behavior, rage or violence;
●Infections or diseases, such as HIV or hepatitis, if you’re injecting the drugs; and
●Inhibited growth and development, with a high risk of future health problems in teenagers. (2)

“Steroid use could potentially pose a huge problem for young athletes, but with a professional consultation and the application of inexpensive solutions such as the CoreControl, the tide can be turned and the downside of premature injuries and so-called ‘roid rage,’ as well as other negative side effects, can be easily avoided,” Chasan said.

Chasan says that with a solid training regimen and adequate rest, all athletes can reach their peak performance without the use of PEDs.

“Athletes who take proper care of their body are doing themselves a favor—artificial enhancements are not only illegal, but also unnecessary and unadvised,” said Chasan.

For more information on CoreControl and other services offered by Sports Reaction Center, visit http://www.srcpt.com.

About the Sports Reaction Center:

Based in Bellevue, Washington and attracting athletes of all levels from the Bellevue, Seattle, Kirkland and Redmond areas, as well as from around the United States, Sports Reaction Center (SRC) was founded by Neil Chasan in 1997. SRC performs sports physical therapy services that incorporate innovative technology such as Dynavision, OptoJump and the NASA-developed Alter-G. The clinic additionally offers concussion management and biomechanical assessment. SRC’s clients include multiple athletes who have qualified for the Olympic Trials in Track and Field, as well as marathoner Mike Sayenko, Olympic hurdler Virginia Powell, and NFL, NBA and MLB players. The clinic also works with area organizations such as Club Northwest, VO2 Multisports, and the Seattle Rugby Club. A graduate of the University of Washington’s physical therapy program in 1982, Chasan is a consultant to the U.S. Olympic Training Center, U.S. Rugby Sports Medicine, and Alter G. Neil is the author of the book Total Conditioning for Golfers, and the creator of the video “The Swing Reaction System”. Neil published “Pain Free Back”, an iPhone application. A clinical faculty member of the University of Washington’s physical therapy program since 1990, Chasan teaches and consults with physical therapists around the world.

1.“Steroids Remain a PR Headache for Baseball.” Bulldogreporter.com. N.p., 24 July 2013. Web. 18 Sept. 2013. bulldogreporter.com/dailydog/article/steroids-remain-a-pr-headache-for-baseball-too-much-braun-not-enough-brains-mlb-ste.

2.“Performance-enhancing Drugs: Know the Risks.” Mayoclinic.com. Mayo Foundation, 12 Dec. 2012. Web. 18 Sept. 2013. mayoclinic.com/health/performance-enhancing-drugs/HQ01105.

Karla Jo Helms, JoTo PR, 888-202-4614 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.